Add Yahoo as a preferred source to see more of our stories on Google. Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since ...

Sprout Pharmaceuticals, Inc. (Sprout), a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized ...

When it comes to a woman's health, Addyi is a vital medication. It can provide relief from the symptoms of female sexual dysfunction and help women to enjoy sex again. With the right insurance ...

Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...

A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...

Health officials have expanded access to a libido-boosting pill for women, approving its use beyond menopause. Flibanserin, sold as Addyi and first cleared by the U.S. Food and Drug Administration ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...

Ten years since the landmark approval of the first and only FDA-authorized pill clinically proven to treat low libido in women, Sprout Pharmaceuticals CEO Cindy Eckert reflects on advancements and ...

On October 17, 2015, a new drug, Addyi (ADD-ee, flibanserin), becomes available to treat the 10 percent of women whose low libido, or “female hypoactive sexual desire disorder,” causes significant ...